Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

N-methylformamide-induced hypophosphatemia

C N Sternberg, A Yagoda

    Cancer Treatment Reports
    |March 1, 1985
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.

    Urologic oncology·2025
    Same author

    Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.

    ESMO open·2023
    Same author

    Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.

    ESMO open·2022
    Same author

    Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study.

    ESMO open·2021
    Same journal

    Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

    Cancer treatment reports·1987
    Same journal

    IV melphalan in children.

    Cancer treatment reports·1987
    Same journal

    Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

    Cancer treatment reports·1987
    Same journal

    Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

    Cancer treatment reports·1987
    Same journal

    Doxorubicin distribution in human breast cancer.

    Cancer treatment reports·1987
    Same journal

    Phase I study of echinomycin.

    Cancer treatment reports·1987
    See all related articles